Clinical effect of terodiline hydrochloride on nervous pollakisuria or irritative bladder
The clinical effect of terodiline hydrochloride (TD-758) was studied in 95 patients with nervous pollakisuria or irritative bladder. TD-758 was given per os randomly at a dose of 24 mg or 12 mg once a day for 4 weeks. The symptoms such as urinary frequency, urinary incontinence and sense of residual...
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 33(1987), 2 vom: 01. Feb., Seite 319-26 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , , , , |
| Format: | Aufsatz |
| Sprache: | Japanese |
| Veröffentlicht: |
1987
|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica |
| Schlagworte: | Clinical Trial English Abstract Journal Article Randomized Controlled Trial Butylamines Calcium Channel Blockers terodiline 70KG06964W |
| Zusammenfassung: | The clinical effect of terodiline hydrochloride (TD-758) was studied in 95 patients with nervous pollakisuria or irritative bladder. TD-758 was given per os randomly at a dose of 24 mg or 12 mg once a day for 4 weeks. The symptoms such as urinary frequency, urinary incontinence and sense of residual urine were improved in 74% of the patients taking 24 mg, and in 51% of the patients taking 12 mg. The difference was statistically significant. Side effects such as dry mouth, constipation and heart burn were observed in 15% of the patients in each group and were not serious. The results of this study indicate that TD-758 is useful for these patients and its optimal dosage is 24 mg once a day |
|---|---|
| Beschreibung: | Date Completed 14.07.1987 Date Revised 15.11.2012 published: Print Citation Status MEDLINE |
| ISSN: | 0018-1994 |